Healthcare Analytical Testing Services Market Size, Share, By Type (Medical device Analytical Testing Services and Pharmaceutical Analytical Testing Services), End-Users (Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies, Cosmetics & Nutraceuticals Companies, Hospitals & Clinics, and Others), and Region - Trends, Analysis, and Forecast till 2035

• The healthcare analytical testing services market size is expected to increase at USD 37.6 Billion by 2035.
• The market size was worth USD 15.9 Billion in 2024.
• The market is expanding at a 9.0% CAGR.

Healthcare analytical testing services are the specialized services used to assess and analyze various aspects of healthcare products, treatments, and medical devices. These services focuses on scientific and technical testing provided by laboratories or pharmaceutical companies. The increasing demand for high quality healthcare products, such as drugs, vaccines and growing investments by pharmaceutical & biotech companies to support research, development and clinical trials, is anticipated to drive healthcare analytical testing services market share.

Impact of AI on Healthcare Analytical Testing Services Market:

Artificial Intelligence (AI) can significantly speed up analytical testing process by reducing the time takes to process test results. Machine learning algorithms can analyze patterns in complex data and improves the accuracy, and precision of analytical tests, by reducing human errors. AI algorithms can analyze large scale healthcare analyst testing data and help to healthcare providers, drug manufactures, and researchers for precise data driven decisions. 

Key Drivers of Target Market:

Growing Investment in Analytical Testing Services is Anticipated to Rise Market Growth

Growing investments in market of healthcare analytical testing services is anticipated to drive market growth, particularly in healthcare, pharmaceutical, and industrial reliability. Many pharmaceutical companies are collaborating to invest in research and development of analytical testing services by the integration of AI, machine learning, and automation. The integration of AI with analytical testing services enables faster, more accurate, and cost-effective testing processes.

• For instance, in October 2024, POLARIS Laboratories received strategic investment from Riverspan Partners, to accelerate innovation and growth in analysis testing services. This investment aimed to support advanced solution, such as HORIZON tools and advanced automation technologies, through laboratory testing and AI enabled software. AI enables software of POLARIS aimed to provide analytical accuracy, insightful and action-oriented recommendation in analytical testing market.

Restraints:

High Costs of Advanced Testing Technologies Disrupt the Target Market Growth

The adoption of advanced testing services, such as AI-driven platforms, and high-throughput testing, comes with high initial investment. For small and medium companies, the initial investment for state-of-the-art equipment, software and training program may be difficult, resulting to disrupt the target market growth.

• Counterbalance Statements: Many companies are adopting outsource testing services to specialized providers, collaborating with manufacturer to reduce initial setup cost, is anticipated to drive healthcare analytical testing services market growth.

Opportunities & Market Trends:

Increasing Collaboration and Strategic Partnership Surge Market Growth

Collaboration between pharmaceutical companies, research institutes and contract research organization allows for testing service particularly in clinical trials and drug development. Collaboration with pharmaceutical companies involve specialized services for clinical trials and regulatory approval processes, such as biomarker discovery or pharmacogenomics testing. Strategic partnership with regulatory bodies, help to ensure testing services and provide financial support to expand testing operations and advance technology, leading to growth of healthcare analytical testing services market size.

• For instance, in January 2025, Canyon Labs, collaborated with iuvo BioScience, to provide medical device and pharmaceutical clinical research services. This collaboration aimed to deliver laboratory services and scientific consulting divisions to Canyon Labs to accelerate their specialized growth in pharmaceutical clinical research services.

The healthcare analytical testing services market is segmented into type, end-user and region.

Type:

Based on type, healthcare analytical testing services market is divided into medical device analytical testing services, pharmaceutical analytical testing services.  Pharmaceutical analytical testing services hold the largest share in the target market due to the increasing demand for drug development and approval processes. As it contains bioanalytical testing of new drugs, biologics, and personalized medicine, thus pharmaceutical industry focuses on target therapies, vaccines, and chronic disease management, resulting to drive healthcare analytical testing services market share.

• For instance, in December 2023, Sterling Accuris Diagnostics acquired Vaibhav Analytical Services, a provider of analytical testing services. This acquisition aimed to expand Sterling Accuris services in pharmaceutical analytical testing. Vaibhav Analytical Services was a service provider to the pharma industries with expertise in pharma analysis, a critical aspect of drug development and manufacturing.

End-user:

Pharmaceutical & biopharmaceutical companies, medical device companies, cosmetics & nutraceuticals companies, hospitals & clinics, and others are end-users for healthcare analytical testing services market. Pharmaceutical and biopharmaceutical companies segment dominates the market, due to growing demand for analytical testing services. These companies require various stages of drug development, discovery, clinical trials, regulatory compliance to ensure the safety, efficacy and quality of drugs, resulting to drive healthcare analytical testing services market growth.

 Region:

Geographically, the market is studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. 

North America: North America holds the largest share with 39.61% in healthcare analytical testing services market, especially in the U.S. Presence of top manufacturing facilities that provide complex, highly reliable and pharmaceutical & medical device products, growing investment in healthcare infrastructure and regulatory approval for clinical trials, anticipated to drive healthcare analytical testing services market share.

• For instance, in September 2024, Pace Life Sciences, LLC, acquired Catalent, a leading global contract research, development, and manufacturing (CDMO) company with operations in the U.S. This acquisition aimed to enhance and strengths of early stage drug research and development to commercialization as a full service analytical outsourcing provider. Pace Company expands service offerings and strengthens network by purchasing Catalent’s Center-of-Excellence for Small Molecule Analytical Services facility in North Carolina.

Asia Pacific: Asia Pacific is expected to be the fastest growing region in target market, due to increasing investments by companies to develop advanced analytical services. Rising burden of diseases, expanding clinical trials, and technological advancement in high-quality analytical testing, is projected to drive of healthcare analytical testing services market growth.

Healthcare Analytical Testing Services Market Report Scope:

Segmentation:

By Type:

• Medical device Analytical Testing Services
  • Extractable and Leachable
  • Material Characterization
  • Physical Testing
  • Bioburden Testing
  • Sterility Testing
  • Others
• Pharmaceutical Analytical Testing Services
  • Bioanalytical Testing
  • Method Development and Validation
  • Stability Testing
  • Others

By End-user:

• Pharmaceutical & Biopharmaceutical Companies and Clinics
• Medical Device Companies
• Cosmetics & Nutraceuticals Companies
• Hospitals & Clinics
• Others

By Region:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • U.K.
  • France
  • Russia
  • Italy
  • Spain
  • Netherlands
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • Indonesia
  • Malaysia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East & Africa

The key players operating in the Healthcare Analytical Testing Services market include Institut Straumann AG, Zimmer Biomet, OSSTEM and others. Companies are adopting strategies, such as new product launches, partnerships, agreement, higher investments and collaboration with other organization for healthcare analytical testing services market growth.

View a additional list of companies in the Healthcare Analytical Testing Services Market:

• Thermo Fisher Scientific, Inc.
• ICON plc
• Sartorius AG
• Labcorp
• Charles River Laboratories
• Syneos Health
• SGS Société Générale de Surveillance SA
• Boston Analytical
• West Pharmaceutical Services, Inc.
• STERIS
• IQVIA
• Eurofins Scientific
• Pace
• Intertek Group plc.
• Medpace

• In October 2024, LGM Pharma, announced the expansion of analytical testing services with endotoxin and rapid sterility testing capabilities. This new services of LGM pharma aimed to offer significant benefits to drug developers, enhanced quality control and cost savings.  LGM Pharma’s newly installed state-of-the-art equipment allows for faster detection and release of drug products, and rapid sterility testing reduces incubation time, which boost data integrity and reduced human error, ensuring high-quality, safe drug products. 
• In February 2024, Thermo Fisher Scientific, Inc., expanded portfolio of good manufacturing practices (GMP) lab services. This expansion aimed to offer biosafety testing capabilities for mycoplasma testing. This new service offered by the analytical testing service of the clinical research, to ensure biopharmaceutical products, aimed to deliver safe medicines for patients.

Analyst View:

Healthcare analytical testing services market is rapidly growing due to advancements in technology, regulatory requirements and the growing demand for high-quality testing in healthcare field. A pharmaceutical and biopharmaceutical companies invest in developing new drugs, biologics, and gene therapies, the demand for analytical testing services increases, especially for biomarker testing, stability testing, and clinical trial support, resulting to growth of target market size in upcoming years.

More Related Reports

Healthcare Biometric Market
Artificial Intelligence in Healthcare Market
Healthcare Finance Solutions Market
Healthcare Automation Market
Food Safety Testing Market